EVERUS CONSTRUCTION GROUP (ECG) Stock Fundamental Analysis
USA - NYSE:ECG - US3004261034 - Common Stock
86.63 USD
-3.6 (-3.99%)
97 USD
+10.37 (+11.97%)
ECG gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 55 industry peers in the Construction & Engineering industry. ECG has an excellent financial health rating, but there are some minor concerns on its profitability. While showing a medium growth rate, ECG is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
ECG had positive earnings in the past year.
ECG had a positive operating cash flow in the past year.
1.2 Ratios
ECG has a better Return On Assets (11.19%) than 80.00% of its industry peers.
ECG's Return On Equity of 32.22% is amongst the best of the industry. ECG outperforms 81.82% of its industry peers.
ECG has a Return On Invested Capital of 18.93%. This is amongst the best in the industry. ECG outperforms 83.64% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ECG is above the industry average of 17.19%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.19% | ||
| ROE | 32.22% | ||
| ROIC | 18.93% |
ROA(3y)11.72%
ROA(5y)N/A
ROE(3y)32.38%
ROE(5y)N/A
ROIC(3y)19.2%
ROIC(5y)N/A
1.3 Margins
With a decent Profit Margin value of 5.07%, ECG is doing good in the industry, outperforming 67.27% of the companies in the same industry.
ECG's Profit Margin has declined in the last couple of years.
The Operating Margin of ECG (6.83%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of ECG has declined.
ECG has a Gross Margin of 11.89%. This is in the lower half of the industry: ECG underperforms 63.64% of its industry peers.
In the last couple of years the Gross Margin of ECG has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.83% | ||
| PM (TTM) | 5.07% | ||
| GM | 11.89% |
OM growth 3Y-2.11%
OM growth 5YN/A
PM growth 3Y-1.91%
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5YN/A
2. Health
2.1 Basic Checks
ECG has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for ECG remains at a similar level compared to 1 year ago.
The debt/assets ratio for ECG is higher compared to a year ago.
2.2 Solvency
ECG has an Altman-Z score of 6.18. This indicates that ECG is financially healthy and has little risk of bankruptcy at the moment.
ECG has a Altman-Z score of 6.18. This is in the better half of the industry: ECG outperforms 78.18% of its industry peers.
ECG has a debt to FCF ratio of 2.24. This is a good value and a sign of high solvency as ECG would need 2.24 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 2.24, ECG is doing good in the industry, outperforming 74.55% of the companies in the same industry.
ECG has a Debt/Equity ratio of 0.53. This is a neutral value indicating ECG is somewhat dependend on debt financing.
ECG has a Debt to Equity ratio (0.53) which is comparable to the rest of the industry.
Even though the debt/equity ratio score it not favorable for ECG, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 2.24 | ||
| Altman-Z | 6.18 |
ROIC/WACC1.82
WACC10.39%
2.3 Liquidity
ECG has a Current Ratio of 1.77. This is a normal value and indicates that ECG is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ECG (1.77) is better than 85.45% of its industry peers.
ECG has a Quick Ratio of 1.69. This is a normal value and indicates that ECG is financially healthy and should not expect problems in meeting its short term obligations.
ECG has a Quick ratio of 1.69. This is amongst the best in the industry. ECG outperforms 87.27% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.77 | ||
| Quick Ratio | 1.69 |
3. Growth
3.1 Past
ECG shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.30%.
The Earnings Per Share has been growing by 9.37% on average over the past years. This is quite good.
ECG shows a decrease in Revenue. In the last year, the revenue decreased by -0.16%.
Measured over the past years, ECG shows a quite strong growth in Revenue. The Revenue has been growing by 11.57% on average per year.
EPS 1Y (TTM)4.3%
EPS 3Y9.37%
EPS 5YN/A
EPS Q2Q%35.26%
Revenue 1Y (TTM)-0.16%
Revenue growth 3Y11.57%
Revenue growth 5YN/A
Sales Q2Q%31.01%
3.2 Future
ECG is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.77% yearly.
The Revenue is expected to grow by 14.58% on average over the next years. This is quite good.
EPS Next Y5.64%
EPS Next 2Y7.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year22.14%
Revenue Next 2Y14.58%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 26.74 indicates a quite expensive valuation of ECG.
ECG's Price/Earnings ratio is a bit cheaper when compared to the industry. ECG is cheaper than 70.91% of the companies in the same industry.
ECG's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.03.
A Price/Forward Earnings ratio of 26.45 indicates a quite expensive valuation of ECG.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ECG indicates a somewhat cheap valuation: ECG is cheaper than 61.82% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.27. ECG is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.74 | ||
| Fwd PE | 26.45 |
4.2 Price Multiples
61.82% of the companies in the same industry are more expensive than ECG, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ECG is valued a bit cheaper than 61.82% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.33 | ||
| EV/EBITDA | 18.47 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ECG does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.74
PEG (5Y)N/A
EPS Next 2Y7.77%
EPS Next 3YN/A
5. Dividend
5.1 Amount
ECG does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
86.63
-3.6 (-3.99%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)
Earnings (Next)
Inst Owners85.88%
Inst Owner Change-1.57%
Ins Owners0.3%
Ins Owner Change15.09%
Market Cap4.42B
Revenue(TTM)3.27B
Net Income(TTM)165.75M
Analysts80
Price Target92.48 (6.75%)
Short Float %3.7%
Short Ratio4.23
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)69.08%
Min EPS beat(2)65.4%
Max EPS beat(2)72.75%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)22.28%
Min Revenue beat(2)21.01%
Max Revenue beat(2)23.55%
Revenue beat(4)4
Avg Revenue beat(4)14.87%
Min Revenue beat(4)3.5%
Max Revenue beat(4)23.55%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.51%
PT rev (3m)28.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.82%
EPS NY rev (1m)0.45%
EPS NY rev (3m)16.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)6.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)9.02%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.74 | ||
| Fwd PE | 26.45 | ||
| P/S | 1.35 | ||
| P/FCF | 34.33 | ||
| P/OCF | 23 | ||
| P/B | 8.59 | ||
| P/tB | 11.91 | ||
| EV/EBITDA | 18.47 |
EPS(TTM)3.24
EY3.74%
EPS(NY)3.28
Fwd EY3.78%
FCF(TTM)2.52
FCFY2.91%
OCF(TTM)3.77
OCFY4.35%
SpS64.08
BVpS10.08
TBVpS7.28
PEG (NY)4.74
PEG (5Y)N/A
Graham Number27.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.19% | ||
| ROE | 32.22% | ||
| ROCE | 25.74% | ||
| ROIC | 18.93% | ||
| ROICexc | 20.98% | ||
| ROICexgc | 25.69% | ||
| OM | 6.83% | ||
| PM (TTM) | 5.07% | ||
| GM | 11.89% | ||
| FCFM | 3.94% |
ROA(3y)11.72%
ROA(5y)N/A
ROE(3y)32.38%
ROE(5y)N/A
ROIC(3y)19.2%
ROIC(5y)N/A
ROICexc(3y)19.99%
ROICexc(5y)N/A
ROICexgc(3y)25.54%
ROICexgc(5y)N/A
ROCE(3y)26.11%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-2.11%
OM growth 5YN/A
PM growth 3Y-1.91%
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5YN/A
F-Score5
Asset Turnover2.21
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 2.24 | ||
| Debt/EBITDA | 1.09 | ||
| Cap/Depr | 233.76% | ||
| Cap/Sales | 1.94% | ||
| Interest Coverage | 11.61 | ||
| Cash Conversion | 76.74% | ||
| Profit Quality | 77.65% | ||
| Current Ratio | 1.77 | ||
| Quick Ratio | 1.69 | ||
| Altman-Z | 6.18 |
F-Score5
WACC10.39%
ROIC/WACC1.82
Cap/Depr(3y)170.58%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.42%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.3%
EPS 3Y9.37%
EPS 5YN/A
EPS Q2Q%35.26%
EPS Next Y5.64%
EPS Next 2Y7.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.16%
Revenue growth 3Y11.57%
Revenue growth 5YN/A
Sales Q2Q%31.01%
Revenue Next Year22.14%
Revenue Next 2Y14.58%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.33%
EBIT growth 3Y9.22%
EBIT growth 5YN/A
EBIT Next Year33.07%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-15.21%
FCF growth 3Y25.55%
FCF growth 5YN/A
OCF growth 1Y-4.65%
OCF growth 3Y24.12%
OCF growth 5YN/A
EVERUS CONSTRUCTION GROUP / ECG FAQ
Can you provide the ChartMill fundamental rating for EVERUS CONSTRUCTION GROUP?
ChartMill assigns a fundamental rating of 5 / 10 to ECG.
What is the valuation status of EVERUS CONSTRUCTION GROUP (ECG) stock?
ChartMill assigns a valuation rating of 2 / 10 to EVERUS CONSTRUCTION GROUP (ECG). This can be considered as Overvalued.
How profitable is EVERUS CONSTRUCTION GROUP (ECG) stock?
EVERUS CONSTRUCTION GROUP (ECG) has a profitability rating of 4 / 10.
What is the valuation of EVERUS CONSTRUCTION GROUP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for EVERUS CONSTRUCTION GROUP (ECG) is 26.74 and the Price/Book (PB) ratio is 8.59.
What is the financial health of EVERUS CONSTRUCTION GROUP (ECG) stock?
The financial health rating of EVERUS CONSTRUCTION GROUP (ECG) is 7 / 10.